Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis.

scientific article

Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-04-3771
P698PubMed publication ID15867368

P50authorYuet-Kin LeungQ56871618
Kin-Mang LauQ58469938
James A MobleyQ60583933
P2093author name stringZhong Jiang
Shuk-Mei Ho
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectoverexpressionQ61643320
ovarian cancerQ172341
carcinogenesisQ1637543
P304page(s)3726-3734
P577publication date2005-05-01
P1433published inCancer ResearchQ326097
P1476titleOverexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis
P478volume65

Reverse relations

cites work (P2860)
Q924513052,3,7,8-Tetrachlorodibenzo-p-dioxin modifies alternative splicing in mouse liver
Q36544917Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: The convolution continues
Q36787314Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.
Q28397525Effects of deletion of the transcription factor Nrf2 and benzo [a]pyrene treatment on ovarian follicles and ovarian surface epithelial cells in mice
Q64128462Enhanced hepatotoxicity induced by repeated exposure to polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin in combination in male rats
Q37379821Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells
Q24673409Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling
Q35196710Estrogens and prostate cancer: etiology, mediators, prevention, and management.
Q35072792Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors.
Q88137353Expression profile of CYP1A1 and CYP1B1 enzymes in endometrial tumors
Q28538733Important role of CYP2J2 in protein kinase inhibitor degradation: a possible role in intratumor drug disposition and resistance
Q38823864Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells
Q41636905Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer
Q33236675Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor
Q47230585Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.
Q40330281Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.
Q24605772α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues